🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. lubiprostone

    Takeda

    Chronic Idiopathic Constipation

    approved small molecule completed

    3 trials

  2. lubiprostone

    Takeda

    Healthy

    approved small molecule completed

    1 trial

  3. lubiprostone (Amitiza)

    Takeda

    Colonoscopy

    approved small molecule completed

    1 trial

  4. midodrine hydrochloride (ProAmatine®)

    Takeda

    Hypotension, Orthostatic

    approved small molecule terminated

    1 trial

  5. pioglitazone

    Takeda

    Type 2 Diabetes

    approved small molecule completed

    1 trial

  6. pioglitazone

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    4 trials

  7. placebo

    Takeda

    Constipation

    approved small molecule completed

    1 trial

  8. prucalopride

    Takeda

    Chronic Constipation

    approved small molecule completed

    1 trial

  9. ramelteon

    Takeda

    Migraine Headache

    approved small molecule terminated

    1 trial

  10. rhPTH (1-84)

    Takeda

    Hypoparathyroidism

    approved mab completed

    3 trials

  11. rhPTH(1-84)

    Takeda

    Chronic Hypoparathyroidism

    approved small molecule terminated

    2 trials

  12. rt-PA

    Takeda

    Lacunar Stroke

    approved small molecule active

    1 trial

  13. theophylline

    Takeda

    Healthy

    approved small molecule completed

    1 trial

  14. vortioxetine

    Takeda

    Depression

    approved small molecule completed

    1 trial

  15. Azilsartan medoximil

    Takeda

    Hypertension

    small molecule completed

    1 trial

  16. Colonoscopy

    Takeda

    CD

    other active

    2 trials

  17. Dexlansoprazole

    Takeda

    Laryngo-pharyngeal Reflux

    small molecule terminated

    1 trial

  18. Febuxostat

    Takeda

    Chronic Kidney Disease

    small molecule completed

    1 trial

  19. Glimepiride

    Takeda

    Type 2 Diabetes

    small molecule active

    1 trial

  20. Gluten

    Takeda

    Celiac Disease

    other completed

    1 trial

  21. Lubiprostone

    Takeda

    Constipation-predominant Irritable Bowel Syndrome

    small molecule completed

    1 trial

  22. Lubiprostone

    Takeda

    Diabetes Mellitus, Type 1

    small molecule terminated

    1 trial

  23. Phentermine

    Takeda

    Obesity

    small molecule completed

    1 trial

  24. Pioglitazone

    Takeda

    Uric Acid Kidney Stone Disease

    small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources